Phytochemicals for the treatment of metabolic diseases: Evidence from clinical studies
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phytochemicals for the treatment of metabolic diseases: Evidence from clinical studies
Authors
Keywords
-
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 165, Issue -, Pages 115274
Publisher
Elsevier BV
Online
2023-08-04
DOI
10.1016/j.biopha.2023.115274
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 55-OR: HSK7653, a Novel Ultralong-Acting DPP-4 Inhibitor, as Monotherapy in Patients With Type 2 Diabetes—A Randomized, Double-Blind, Placebo-Controlled Phase III Trial
- (2023) LINONG JI et al. DIABETES
- Therapeutic Effect of Curcumin on Metabolic Diseases: Evidence from Clinical Studies
- (2023) Yujiao Zeng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
- (2023) Julio Rosenstock et al. LANCET
- Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus
- (2022) Leilei Du et al. BIOMEDICINE & PHARMACOTHERAPY
- Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives
- (2022) Jasvinder Singh Bhatti et al. FREE RADICAL BIOLOGY AND MEDICINE
- Yogliptin monotherapy in type 2 diabetes: A 12‐week randomized, double‐blind, placebo‐controlled phase II study
- (2022) Xin Wang et al. Journal of Diabetes
- Potential of anthocyanin as an anti-inflammatory agent: a human clinical trial on type 2 diabetic, diabetic at-risk and healthy adults
- (2021) Elham Nikbakht et al. INFLAMMATION RESEARCH
- The therapeutic effects and mechanisms of salidroside on cardiovascular and metabolic diseases: An updated review
- (2021) Cheng-Cheng Zhao et al. CHEMISTRY & BIODIVERSITY
- Inflammatory markers response to crocin supplementation in patients with type 2 diabetes mellitus: A randomized controlled trial
- (2021) Vahideh Behrouz et al. PHYTOTHERAPY RESEARCH
- The effect of curcumin and zinc co‐supplementation on glycemic parameters in overweight or obese prediabetic subjects: A phase 2 randomized, placebo‐controlled trial with a multi‐arm, parallel‐group design
- (2021) Majid Karandish et al. PHYTOTHERAPY RESEARCH
- Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double‐blind, placebo‐controlled, clinical trial
- (2021) Zahra Namkhah et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- The Therapeutic Effects and Mechanisms of Quercetin on Metabolic Diseases: Pharmacological Data and Clinical Evidence
- (2021) Huan Yi et al. Oxidative Medicine and Cellular Longevity
- Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial
- (2021) Fatemeh Naeini et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
- (2021) David C W Lau et al. LANCET
- Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial
- (2020) Maryam Saberi-Karimian et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Tropifexor, a highly potent FXR agonist, produces robust and dose-dependent reductions in hepatic fat and serum alanine aminotransferase in patients with fibrotic NASH after 12 weeks of therapy: FLIGHT-FXR Part C interim results
- (2020) K.J. Lucas et al. DIGESTIVE AND LIVER DISEASE
- Magnoflorine: A review of its pharmacology, pharmacokinetics and toxicity
- (2020) Tong Xu et al. PHARMACOLOGICAL RESEARCH
- The effect of resveratrol supplementation on serum levels of asymmetric de‐methyl‐arginine and paraoxonase 1 activity in patients with type 2 diabetes: A randomized, double‐blind controlled trial
- (2020) Mahtab Tabatabaie et al. PHYTOTHERAPY RESEARCH
- Genistein stimulates insulin sensitivity through gut microbiota reshaping and skeletal muscle AMPK activation in obese subjects
- (2020) Martha Guevara-Cruz et al. BMJ Open Diabetes Research & Care
- A pilot study of the effect of curcumin on epigenetic changes and DNA damage among patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, clinical trial
- (2020) Mitra Hariri et al. COMPLEMENTARY THERAPIES IN MEDICINE
- The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial
- (2020) Zahra Yari et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis
- (2020) Stephen A. Harrison et al. GASTROENTEROLOGY
- Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD
- (2020) Antonella Mosca et al. DIGESTIVE AND LIVER DISEASE
- Randomized double‐blind clinical trial examining the Ellagic acid effects on glycemic status, insulin resistance, antioxidant, and inflammatory factors in patients with type 2 diabetes
- (2020) Mahnaz Ghadimi et al. PHYTOTHERAPY RESEARCH
- Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence
- (2020) Xinmei Xu et al. BIOMEDICINE & PHARMACOTHERAPY
- Seed peptide lunasin ameliorates obesity-induced inflammation and regulates immune responses in C57BL/6J mice fed high-fat diet
- (2020) Chia-Chien Hsieh et al. FOOD AND CHEMICAL TOXICOLOGY
- The effects of curcumin supplementation on high-sensitivity C-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial
- (2019) Mahsa Adibian et al. PHYTOTHERAPY RESEARCH
- Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial
- (2019) Seyed Ali Jazayeri-Tehrani et al. Nutrition & Metabolism
- Obesity: global epidemiology and pathogenesis
- (2019) Matthias Blüher Nature Reviews Endocrinology
- Pinitol consumption improves liver health status by reducing oxidative stress and fatty acid accumulation in subjects with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial
- (2019) Eunok Lee et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial
- (2019) Arrigo F. G. Cicero et al. EUROPEAN JOURNAL OF NUTRITION
- Effectiveness of genistein supplementation on metabolic factors and antioxidant status in postmenopausal women with type-2 diabetes mellitus
- (2019) Hassan Braxas et al. Canadian Journal of Diabetes
- Circulating Oxidative Stress Biomarkers in Clinical Studies on Type 2 Diabetes and Its Complications
- (2019) Elisabetta Bigagli et al. Oxidative Medicine and Cellular Longevity
- The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: a randomized, double-blind clinical trial
- (2019) Homa Hodaei et al. Diabetology & Metabolic Syndrome
- Curcuminoids plus piperine improve nonalcoholic fatty liver disease: A clinical trial
- (2019) Yunes Panahi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Effects of curcumin supplementation on markers of inflammation and oxidative stress among healthy overweight and obese girl adolescents: A randomized placebo‐controlled clinical trial
- (2019) Sahar Saraf‐Bank et al. PHYTOTHERAPY RESEARCH
- Effects of Highly Absorbable Curcumin in Patients with Impaired Glucose Tolerance and Non-Insulin-Dependent Diabetes Mellitus
- (2019) Masafumi Funamoto et al. Journal of Diabetes Research
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial
- (2018) ShadiSadat Seyyedebrahimi et al. ACTA DIABETOLOGICA
- Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial
- (2018) Sasan Amanat et al. CLINICAL NUTRITION
- Acute administration of capsaicin increases resting energy expenditure in young obese subjects without affecting energy intake, appetite, and circulating levels of orexigenic/anorexigenic peptides
- (2018) Antonello E. Rigamonti et al. NUTRITION RESEARCH
- Resveratrol supplementation decreases blood glucose without changing the circulating CD14 + CD16 + monocytes and inflammatory cytokines in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study
- (2018) Hadi Khodabandehloo et al. NUTRITION RESEARCH
- Gut Microbes and Health: A Focus on the Mechanisms Linking Microbes, Obesity, and Related Disorders
- (2018) Marialetizia Rastelli et al. Obesity
- Blood pressure lowering and anti-inflammatory effects of hesperidin in type 2 diabetes; a randomized double-blind controlled clinical trial
- (2018) Fatemeh Homayouni et al. PHYTOTHERAPY RESEARCH
- The effects of quercetin supplementation on metabolic and hormonal parameters as well as plasma concentration and gene expression of resistin in overweight or obese women with polycystic ovary syndrome
- (2018) Masoud Khorshidi et al. PHYTOTHERAPY RESEARCH
- Efficacy of phospholipidated curcumin in nonalcoholic fatty liver disease: a clinical study
- (2018) Yunes Panahi et al. JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH
- Obesity, diabetes, and the gut microbiome: an updated review
- (2018) Tahli Singer-Englar et al. Expert Review of Gastroenterology & Hepatology
- Type 2 diabetes
- (2017) Sudesna Chatterjee et al. LANCET
- Hesperidin Supplementation Alleviates Oxidative DNA Damage and Lipid Peroxidation in Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Clinical Trial
- (2017) Fatemeh Homayouni et al. PHYTOTHERAPY RESEARCH
- Metabolism disrupting chemicals and metabolic disorders
- (2017) Jerrold J. Heindel et al. REPRODUCTIVE TOXICOLOGY
- Anthocyanin supplementation in alleviating thrombogenesis in overweight and obese population: A randomized, double-blind, placebo-controlled study
- (2017) Kiara Thompson et al. Journal of Functional Foods
- Role of Purified Anthocyanins in Improving Cardiometabolic Risk Factors in Chinese Men and Women with Prediabetes or Early Untreated Diabetes—A Randomized Controlled Trial
- (2017) Liping Yang et al. Nutrients
- Serum aminotransferases in nonalcoholic fatty liver disease are a signature of liver metabolic perturbations at the amino acid and Krebs cycle level1,2
- (2016) Silvia Sookoian et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Therapeutic effect of high-dose green tea extract on weight reduction: A randomized, double-blind, placebo-controlled clinical trial
- (2016) I-Ju Chen et al. CLINICAL NUTRITION
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Natural Products to Counteract the Epidemic of Cardiovascular and Metabolic Disorders
- (2016) Birgit Waltenberger et al. MOLECULES
- Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial
- (2016) Sepideh Rahmani et al. PHYTOTHERAPY RESEARCH
- The Impact of Resveratrol Supplementation on Blood Glucose, Insulin, Insulin Resistance, Triglyceride, and Periodontal Markers in Type 2 Diabetic Patients with Chronic Periodontitis
- (2016) Ahmad Zare Javid et al. PHYTOTHERAPY RESEARCH
- Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial
- (2016) Yunes Panahi et al. INFLAMMOPHARMACOLOGY
- Impact of sub-gastrectomy on glucose regulation in gastric cancer patients with T2DM: a follow-up study
- (2015) You Cheng Zhang et al. International Journal of Diabetes in Developing Countries
- Purified Anthocyanin Supplementation Reduces Dyslipidemia, Enhances Antioxidant Capacity, and Prevents Insulin Resistance in Diabetic Patients
- (2015) Dan Li et al. JOURNAL OF NUTRITION
- Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
- (2015) Hong-Mei Yan et al. PLoS One
- Meta-analysis of Atherogenic Index of Plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus
- (2015) Xiao-Wei Zhu et al. Primary Care Diabetes
- Evaluation of the Effect of Curcumin Capsules on Glyburide Therapy in Patients with Type-2 Diabetes Mellitus
- (2014) Prasad Neerati et al. PHYTOTHERAPY RESEARCH
- Investigation of the Effects of Curcumin on Serum Cytokines in Obese Individuals: A Randomized Controlled Trial
- (2014) Shiva Ganjali et al. TheScientificWorldJOURNAL
- Diabetes in China: a societal solution for a personal challenge
- (2014) Juliana C N Chan et al. Lancet Diabetes & Endocrinology
- Effects of curcumin on brain-derived neurotrophic factor levels and oxidative damage in obesity and diabetes
- (2013) Elena Franco-Robles et al. Applied Physiology Nutrition and Metabolism
- The effects of 30 days resveratrol supplementation on adipose tissue morphology and gene expression patterns in obese men
- (2013) E Konings et al. INTERNATIONAL JOURNAL OF OBESITY
- Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial
- (2013) Somlak Chuengsamarn et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease
- (2013) Melania Gaggini et al. Nutrients
- Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis
- (2012) X. Wang et al. DIABETES CARE
- Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial
- (2012) Li-Xin Na et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
- (2012) Jayesh Kumar Bhatt et al. NUTRITION RESEARCH
- Lipid-lowering effect of berberine in human subjects and rats
- (2012) Yueshan Hu et al. PHYTOMEDICINE
- Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients
- (2011) Pál Brasnyó et al. BRITISH JOURNAL OF NUTRITION
- Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
- (2011) Silvie Timmers et al. Cell Metabolism
- National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants
- (2011) Mariel M Finucane et al. LANCET
- The Role of Cytokines in Non-Alcoholic Fatty Liver Disease
- (2010) Herbert Tilg DIGESTIVE DISEASES
- Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study
- (2009) Sarah Egert et al. BRITISH JOURNAL OF NUTRITION
- Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial
- (2009) Manal F. Abdelmalek et al. HEPATOLOGY
- Circulating oxidized LDL levels, current smoking and obesity in postmenopausal women
- (2008) E. Kassi et al. ATHEROSCLEROSIS
- Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine
- (2008) Yifei Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy of berberine in patients with type 2 diabetes mellitus
- (2008) Jun Yin et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effect of NCB-02, Atorvastatin and Placebo on Endothelial Function, Oxidative Stress and Inflammatory Markers in Patients with Type 2 Diabetes Mellitus
- (2008) P Usharani et al. Drugs in research & development
- Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet
- (2007) Maiana Verdelho Machado et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started